Beta-Glucan Viscosity Control for Cholesterol Reduction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The relationship between the viscosity, molecular weight, and solubility of β-glucan and its effects on cholesterol-lowering, glycemic response, and appetite regulation is not well understood, leading to variability in the effectiveness of β-glucan-containing products in reducing serum LDL cholesterol and regulating glycemic response.

Innovation Solution

A dietary fibre composition with β-glucan selected to have a peak molecular weight in the range of 500 kDa to 3000 kDa and a solubility of at least 50% is used, which increases the viscosity of intestinal contents, thereby effectively lowering LDL cholesterol and regulating glycemic response, even at a low content in food products.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If β-glucan is used to reduce LDL cholesterol and regulate glycemic response, then health benefits are improved, but the relationship between viscosity, molecular weight, and solubility is not well understood leading to variability in effectiveness

Engineering Contradiction:
Improveeffectiveness of cholesterol-lowering and glycemic response regulationVSAvoidunderstanding of relationship between viscosity, molecular weight, and solubility
Core Design Contradiction:
ReliabilityVSLoss of information

Solution Approach 1:

The patent applies parameter changes by establishing specific ranges for molecular weight (500-3000 kDa peak molecular weight) and solubility (at least 50% solubility) of β-glucan to optimize its physiological effects. This resolves the contradiction by providing concrete parameter specifications that ensure reliable cholesterol-lowering and glycemic response regulation while reducing variability in effectiveness.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If β-glucan with high molecular weight and high solubility is selected to increase viscosity of intestinal contents, then cholesterol-lowering effect is improved, but the complexity of selecting and characterizing specific β-glucan properties increases

Engineering Contradiction:
Improvecholesterol-lowering effectVSAvoidcomplexity of β-glucan selection and characterization
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent specifies concrete parameter ranges (molecular weight 500-3000 kDa, solubility ≥50%) to achieve reliable cholesterol-lowering effects without requiring complex characterization procedures. This resolves the contradiction by providing clear, measurable parameters that balance effectiveness with practical selectability.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent uses readily available cereal-based β-glucan sources (oats, barley, rye, wheat) that can be extracted using simple aqueous methods, avoiding the need for complex or expensive specialized materials. This resolves the contradiction by providing an accessible, cost-effective source that meets the specified parameter requirements.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Ease of operation

If β-glucan is extracted to be soluble in water for dietary fibre composition, then functional value is improved, but the extraction and characterization process becomes more complex

Engineering Contradiction:
Improvefunctional value of dietary fibreVSAvoidextraction and characterization process
Core Design Contradiction:
Ease of operationVSDevice complexity

Solution Approach 1:

The patent employs simple aqueous extraction methods using common buffers (e.g., phosphate buffer) to solubilize β-glucan from cereal sources, avoiding complex extraction procedures. This resolves the contradiction by achieving high solubility (≥50%) and functional value through straightforward, cost-effective extraction processes.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The composition achieves significant LDL cholesterol reduction and glycemic response regulation by enhancing the viscosity of intestinal contents, demonstrating a direct correlation between molecular weight, concentration, and viscosity of solubilized β-glucan, leading to improved physiological effects.

Implementation Method 1

when ingested, the soluble β-glucan is not hydrolysed by digestive systems of the human upper gastrointestinal tract, but absorbs water either to disperse into the digestive lumen, or to form a swollen, gelatinous cell wall residue

Methodology Applied
Scientific EffectAbsorption: Absorption (physical)

Implementation Method 2

β-glucan is selected to have a peak molecular weight in the range of 500 kDa to 3000 kDa, a solubility at 37°C of at least 50% of extracted β-glucan to the total β-glucan content in an extract of the fibre composition, and with a viscosity of the extract at 37°C of at least 500 mPa·s

Methodology Applied
Scientific EffectViscosity enhancement:

Data Source

PatentEP2506860B1Dietary fibre composition containing beta-glucan
Publication Date: 2016.10.05 SWEDISH OAT FIBER
  • EP2506860B1 patent drawingFigure 1
  • EP2506860B1 patent drawingFigure 2
  • EP2506860B1 patent drawingFigure 3~4

AI summary

A dietary fibre composition comprising at least one cereal grain component containing ß-glucans having a combination of MW and solubility that will produce a sufficiently high viscosity to provide a beneficial effect at comparatively low contents of ß-glucans in the fibre composition.